Title: "Recall Alert: Over 141,000 Bottles of Atorvastatin Calcium Tablets Recalled Due to Dissolution Issues
A recall has been issued for over 141,000 bottles of cholesterol medication due to failed dissolution specifications, indicating that the drugs did not dissolve properly. The recall was initiated by Ascend Laboratories, LLC, a pharmaceutical company based in New Jersey. The affected medication is atorvastatin calcium tablets, with bottles containing 10mg, 20mg, 40mg, and 80mg tablets being recalled. The recall is classified as a "Class II" recall, suggesting that the use of the affected product may cause temporary or medically reversible adverse health consequences.
The atorvastatin calcium tablets were manufactured by Alkem Laboratories, Ltd., of India, and distributed by Ascend. The recall includes bottles with different quantities of tablets, ranging from 90-count to 1000-count bottles. The specific information on the recalled medication, such as lot codes and expiration dates, can be found in the FDA's enforcement report. Consumers who have the recalled medication are advised to consult with their doctor or pharmacist, but can generally continue taking the medicine unless instructed otherwise by the recalling company.
Atorvastatin calcium is a medication used to control cholesterol levels and reduce the risk of heart attacks or strokes. It is commonly known by the brand name Lipitor, manufactured by Pfizer. Statins, including atorvastatin calcium, are among the most prescribed drugs in the United States, with over 40 million Americans estimated to be taking them. If you have any of the recalled medication, it is important to follow the guidance provided by healthcare professionals to ensure your health and safety.
In conclusion, a recall has been issued for atorvastatin calcium tablets due to failed dissolution specifications, prompting Ascend Laboratories, LLC, to recall over 141,000 bottles of the medication. Consumers are advised to consult with their healthcare providers if they have the recalled medication and to follow any instructions provided by the recalling company to ensure their well-being.